Spots Global Cancer Trial Database for Concurrent Xeloda and Radiotherapy for Bone Metastases
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Concurrent Xeloda and Radiotherapy for Bone Metastases
Official Title: Concurrent Xeloda and Radiotherapy for Bone Metastases
Study ID: NCT00192777
Study Description
Brief Summary: Hypothesis: Radiosensitization using Xeloda should improve the rate of complete pain relief. Primary Objective: * To determine the frequency of pain relief for the proposed regimen. Secondary Objective(s): * To determine the duration of pain relief and narcotic relief for the proposed regimen. * To determine the frequency of narcotic relief for the proposed regimen. * To determine the toxicity of concurrent UFT and radiotherapy in patients with bone metastases.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Rambam Health Care Campus, Haifa, , Israel
Contact Details
Name: Kuten Abraham, Prof.
Affiliation: Dept. of Oncology, Rambam Health Care Campus
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
